Skip to main content
Clinical Trials/NCT06732635
NCT06732635
Completed
Phase 3

Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer: A Randomized Controlled Trial

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia1 site in 1 country68 target enrollmentJune 1, 2019

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Endometrial Cancer
Sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Enrollment
68
Locations
1
Primary Endpoint
Lengh of stay
Status
Completed
Last Updated
last year

Overview

Brief Summary

Enhanced recovery after surgery (ERAS) programs are designed to achieve early recovery after surgery and a shorter length of stay (LOS) at hospital.

So far there are only three prospective, randomised studies that exclusively analyze patients affected by oncogynecological pathology providing a high level of scientific evidence. To our knowledge, no studies have been conducted specifically on ERAS pathways in endometrial cancer treated by laparoscopy. This study aims to evaluate whether ERAS pathways are beneficial for patients with endometrial cancer, particularly among low-risk early endometrial cancer operated by laparoscopy. Length of stay (LOS), perioperative morbidity and mortality, and perioperative quality of life were analyzed comparing both ERAS and Conventional protocols groups.

Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
March 1, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing laparoscopic hysterectomy for stage 1A and 1B endometrial cancer

Exclusion Criteria

  • Age under 18 years
  • Liver cirrhosis
  • Psychiatric illness
  • Urgent surgery
  • The patient's desire not to participate.

Outcomes

Primary Outcomes

Lengh of stay

Time Frame: 30 days after surgery

Days of hospitalitation

Day of discharge

Time Frame: 30 days after surgery

Readmisión

Time Frame: During 1st month after surgery

yes/no

Study Sites (1)

Loading locations...

Similar Trials